SensoDetect AB is proud to announce the opening of its new office and clinical site at The Park Forskaren, Hagaplan 4, Stockholm, located adjacent to the world-renowned Karolinska Institute. This strategic move places SensoDetect in the heart of Sweden’s foremost life science and innovation district, reinforcing the company’s commitment to advancing early and objective diagnostics for neuropsychiatric conditions. 

From this location, SensoDetect will officially launch its ADHD and autism (ASD) screening services, utilizing its patented BERA (Brainstem Evoked Response Audiometry) technology to provide fast, reliable, and evidence-based diagnostic support. 

"Opening at The Park Forskaren is a major step forward for us. Being right next to Karolinska Institute allows us to collaborate more closely with leading minds in medicine and research, while making our services more accessible to patients and clinicians alike. We are now ready to offer our breakthrough screening services for ADHD and Autism to the Stockholm community and beyond," says CEO Per-Anders (PA) Hedin. 

In addition to the new office launch, SensoDetect is also pleased to announce the appointment of Karl Vilhelm Lundin as Vice President of Business Development. With a strong background in commercial strategy, Mr. Lundin will play a key role in scaling SensoDetect’s operations and partnerships across Europe and beyond. 

For partnership inquiries or booking of a screening please contact Karl Vilhelm Lundin: 
Mobile: +46 70-748 31 01 
Email: kv.lundin@sensodetect.com